Clinical application of personalized rheumatoid arthritis risk information: Translational epidemiology leading to precision medicine
Expert Rev Precis Med Drug Dev
.
2021;6(3):147-149.
doi: 10.1080/23808993.2021.1857237.
Epub 2020 Dec 14.
Author
Jeffrey A Sparks
1
2
Affiliations
1
Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, USA.
2
Harvard Medical School, 25 Shattuck Street, Boston, MA, USA.
PMID:
34124370
PMCID:
PMC8192070
DOI:
10.1080/23808993.2021.1857237
No abstract available
Keywords:
genetics; intervention; personalized medicine; precision medicine; rheumatoid arthritis.
Grants and funding
P30 AR072577/AR/NIAMS NIH HHS/United States
P30 AR070253/AR/NIAMS NIH HHS/United States
K23 AR069688/AR/NIAMS NIH HHS/United States
L30 AR066953/AR/NIAMS NIH HHS/United States
R03 AR075886/AR/NIAMS NIH HHS/United States